FR2265389A1 - - Google Patents

Info

Publication number
FR2265389A1
FR2265389A1 FR7510140A FR7510140A FR2265389A1 FR 2265389 A1 FR2265389 A1 FR 2265389A1 FR 7510140 A FR7510140 A FR 7510140A FR 7510140 A FR7510140 A FR 7510140A FR 2265389 A1 FR2265389 A1 FR 2265389A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7510140A
Other languages
French (fr)
Other versions
FR2265389B1 (fi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of FR2265389A1 publication Critical patent/FR2265389A1/fr
Application granted granted Critical
Publication of FR2265389B1 publication Critical patent/FR2265389B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7510140A 1974-04-01 1975-04-01 Expired FR2265389B1 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45679774A 1974-04-01 1974-04-01
US54722775A 1975-02-05 1975-02-05
US55496675A 1975-03-03 1975-03-03

Publications (2)

Publication Number Publication Date
FR2265389A1 true FR2265389A1 (fi) 1975-10-24
FR2265389B1 FR2265389B1 (fi) 1978-07-28

Family

ID=27412681

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7510140A Expired FR2265389B1 (fi) 1974-04-01 1975-04-01

Country Status (14)

Country Link
JP (1) JPS5427360B2 (fi)
CA (1) CA1033731A (fi)
DD (1) DD119425A5 (fi)
DE (1) DE2513930A1 (fi)
DK (1) DK138743B (fi)
ES (1) ES436155A1 (fi)
FI (1) FI750891A (fi)
FR (1) FR2265389B1 (fi)
GB (1) GB1451423A (fi)
IE (1) IE40893B1 (fi)
IL (1) IL46864A0 (fi)
LU (1) LU72184A1 (fi)
NL (1) NL7503692A (fi)
PH (1) PH10464A (fi)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364213A1 (fr) * 1976-09-13 1978-04-07 Pfizer Nouveaux acides 5-alkoxyimidazo(1,2-a) quinoleine-2-carboxyliques et leurs derives et composition pharmaceutique les contenant
EP0080941A1 (fr) * 1981-11-27 1983-06-08 Roussel-Uclaf Nouvelles pyrimido quinoxalines et leurs sels, leur préparation, leur application à titre de médicaments et les compositions les renfermant

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127720A (en) * 1977-09-21 1978-11-28 Bristol-Myers Company Pyrimido[2,1-a]isoquinoline derivatives having antiallergy activity
US4209620A (en) * 1978-06-19 1980-06-24 Bristol-Myers Company Substituted 3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives having antiallergy activity
US4510143A (en) * 1982-02-17 1985-04-09 Roussel Uclaf Antiallergic pyrimido[1,2-a]quinoxalin-2-carboxylic acid derivatives
WO1997037999A1 (en) * 1996-04-04 1997-10-16 University Of Nebraska Board Of Regents Synthetic triple helix-forming compounds
US6989392B2 (en) 2002-06-18 2006-01-24 Abbott Laboratories 2-Aminoquinolines as melanin concentrating hormone receptor antagonists

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364213A1 (fr) * 1976-09-13 1978-04-07 Pfizer Nouveaux acides 5-alkoxyimidazo(1,2-a) quinoleine-2-carboxyliques et leurs derives et composition pharmaceutique les contenant
EP0080941A1 (fr) * 1981-11-27 1983-06-08 Roussel-Uclaf Nouvelles pyrimido quinoxalines et leurs sels, leur préparation, leur application à titre de médicaments et les compositions les renfermant

Also Published As

Publication number Publication date
IE40893L (en) 1975-10-01
JPS5427360B2 (fi) 1979-09-10
PH10464A (en) 1977-04-25
IL46864A0 (en) 1975-05-22
DE2513930A1 (de) 1975-10-02
IE40893B1 (en) 1979-09-12
DD119425A5 (fi) 1976-04-20
CA1033731A (en) 1978-06-27
DK138743C (fi) 1979-04-02
FR2265389B1 (fi) 1978-07-28
DK130475A (fi) 1975-10-02
GB1451423A (en) 1976-10-06
DK138743B (da) 1978-10-23
FI750891A (fi) 1975-10-02
NL7503692A (nl) 1975-10-03
LU72184A1 (fi) 1976-03-02
ES436155A1 (es) 1977-02-01
AU7937775A (en) 1976-09-23
JPS50140499A (fi) 1975-11-11

Similar Documents

Publication Publication Date Title
FR2281998B3 (fi)
FI750358A (fi)
FR2263320B3 (fi)
FR2275827B3 (fi)
FR2265389B1 (fi)
FR2269181B1 (fi)
FR2289175B1 (fi)
FR2278950B1 (fi)
AU495920B2 (fi)
CS175689B1 (fi)
AU7138274A (fi)
AU7099174A (fi)
BG20667A1 (fi)
CH1357474A4 (fi)
BG19873A1 (fi)
BG19982A1 (fi)
BG19828A1 (fi)
BG20001A1 (fi)
BG20159A1 (fi)
BG19772A1 (fi)
DD124114A5 (fi)
DD117100A1 (fi)
BG20443A1 (fi)
BG19607A1 (fi)
CH596584A5 (fi)

Legal Events

Date Code Title Description
ST Notification of lapse